AC
EVGN icon

Armistice Capital’s Evogene EVGN Stock Holding History

Armistice Capital’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Buy
+456,587
New +$431K 0.01% 186
2025
Q2 		– Sell
-316,024
Closed -$395K – 224
2025
Q1 		$395K Buy
316,024
+17,743
+6% +$26.8K 0.01% 184
2024
Q4 		$558K Buy
298,281
+103,589
+53% +$204K 0.01% 176
2024
Q3 		$598K Buy
+194,692
New +$840K 0.01% 185

Other funds holding EVGN

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TCM
Tradewinds Capital Management Bellingham, Washington $504M AUM 40.92% 1-Year Est. Return

Armistice Capital's EVGN Position: Q1 2026 in Review

Armistice Capital opened a new position in Evogene (EVGN) in Q1 2026: 456,587 shares worth $352K. The stake represents 0.01% of the portfolio and ranks #186 among its holdings. This is a return to the name: Armistice Capital previously reported a position in EVGN as recently as Q1 2025.

Armistice Capital first reported a position in EVGN in Q3 2024 and has held it in 4 quarters since. The position peaked at $598K in Q3 2024. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

  • Armistice Capital held 456,587 shares of Evogene worth $352K as of Q1 2026.
  • Evogene was a new Armistice Capital position in Q1 2026.
  • Evogene made up 0.01% of Armistice Capital's portfolio in Q1 2026, its #186 holding.
  • Armistice Capital first reported a position in Evogene in Q3 2024 and has held it in 4 quarters since.
  • Armistice Capital's Evogene position peaked at $598K in Q3 2024.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.